Tai-Heng Cheng leads the New York international arbitration practice of Quinn Emanuel Urquhart & Sullivan. He has achieved numerous victories in investor-state and commercial arbitrations, worldwide, as well as in US litigation and regulatory investigations.
With over 15 years of experience as an attorney, Dr. Cheng has also served as tribunal chair or co-arbitrator in more than a dozen arbitrations with $8bn. to $5mn. at stake, and is a member of the arbitration panels of arbitration institutions in North America, Europe and Asia.
Dr. Cheng has been recognized in Chambers Global and Chambers USA for international arbitration, GAR and “Who’s Who Legal: Arbitration Future Leaders 2017,” Benchmark Litigation’s “Rising Stars,” Benchmark Litigation’s “Under 40 Hot List,” as well as in Euromoney’s “Guide to the World’s Leading Experts in Commercial Arbitration.” The chair of a tribunal before which Dr. Cheng appeared as lead counsel, winning full damages and 90% of fees and costs, described Dr. Cheng "as one of the most outstanding advocates" that he had met in over three decades as an arbitrator and judge. A Stockholm Chamber of Commerce arbitration tribunal issued an award praising Dr. Cheng's presentation at the hearing as "a remarkably eloquent and intelligent address . . . with which the arbitrators of course full-heartedly agree in all respects.” In affirming an award rendered by Dr. Cheng, a U.S. court has complemented the award as “thorough and well-reasoned.”
He is an elected fellow of the College of Commercial Arbitrators, the American Law Institute and the Foreign Policy Association, and serves on the boards of several professional and civic associations.
Prior to joining the firm, Dr. Cheng was a tenured professor of international law in the United States. U.S. Federal Circuit and District Courts have cited and relied on his scholarship as authoritative. Dr. Cheng has a J.S.D. and LL.M. degree from Yale Law School and first class honors in law from Oxford University.
Dr. Cheng is bilingual in English and Mandarin.